Montana lets clinics charge for experimental treatments after Phase 1 safety trials only
A new state law opens access to investigational treatments for patients with any condition — the first in the US to let companies bill for experimental care. Protocols need sign-off from a private review board, not the FDA, and only about one in ten drugs that reach this stage are ever fully approved.
3 min read